MSH|^~\&|PTH|SMH|||201911281042||ORU^R01|4115863|D|2.3|||AL|NE PID|1||SM00041940|LM4541|TEST^ADM^MATILDA||19820507|F||||||||||SM001657/18|9876479911 PV1|1|O OBR|1|22044|00016632^19RS-1^PTH^19RS-1^22044||||201902041000||||||MFM|201902051108|S^SURGICAL SPECIMEN^SURGICAL|||||19RS-1||201911281042|||SOUT OBX|1|TX|Pathology Lab: Royal Columbian Hospital OBX|2|TX|Phone: (604)520-4352 Fax: (604)520-4409 OBX|3|TX| OBX|4|TX|Specimen Number: 19RS-1 OBX|5|TX| OBX|6|TX|DIAGNOSES OBX|7|TX|TESTING BIZTALK 2013 OBX|8|TX| OBX|9|TX|SYNOPTIC REPORT OBX|10|TX|-------- Anus - Abdominoperineal Resection, 1 -------- OBX|11|TX| OBX|12|TX|SPECIMEN COMMENT OBX|13|TX| Pertains To: test OBX|14|TX| OBX|15|TX|SPECIMEN OBX|16|TX| Procedure: Abdominoperineal resection OBX|17|TX| OBX|18|TX|TUMOUR OBX|19|TX| Tumour Site: Perianal region OBX|20|TX| Tumour Size: 4 x 3 Centimeters (cm) OBX|21|TX| Histologic Type: Adenocarcinoma OBX|22|TX| Histologic Grade: G3: Poorly differentiated OBX|23|TX| Tumour Extension: Tumour directly invades adjacent structures OBX|24|TX| - test OBX|25|TX| OBX|26|TX|MARGINS OBX|27|TX| All margins are negtive for invasive OBX|28|TX| carcinoma and high-grade intraepithelial OBX|29|TX| neoplasia OBX|30|TX| Margins Examined: Proximal OBX|31|TX| OBX|32|TX|LYMPH NODES, REGIONAL OBX|33|TX| No lymph nodes present OBX|34|TX| OBX|35|TX|TREATMENT EFFECT OBX|36|TX| No known presurgical therapy OBX|37|TX| OBX|38|TX|PATHOLOGIC STAGE OBX|39|TX| pT4 pNX OBX|40|TX| OBX|41|TX|ANCILLARY STUDIES OBX|42|TX| Best Tumour Block(s): test OBX|43|TX| OBX|44|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|45|TX|---------- End of Synoptic Report ---------- OBX|46|TX|-------- Anus - Abdominoperineal Resection, 2 -------- OBX|47|TX| OBX|48|TX|SPECIMEN COMMENT OBX|49|TX| Pertains To: TESTING V.7.0.0.5 OBX|50|TX| OBX|51|TX|SPECIMEN OBX|52|TX| Procedure: Abdominoperineal resection OBX|53|TX| OBX|54|TX|TUMOUR OBX|55|TX| Tumour Site: Perianal region OBX|56|TX| Tumour Size: 5.0 Centimeters (cm) OBX|57|TX| Histologic Type: Adenocarcinoma OBX|58|TX| Histologic Grade: G3: Poorly differentiated OBX|59|TX| Tumour Extension: Tumour directly invades adjacent structures OBX|60|TX| - test test test OBX|61|TX| OBX|62|TX|MARGINS OBX|63|TX| All margins are negative for invasive OBX|64|TX| carcinoma and high-grade intraepithelial OBX|65|TX| neoplasia OBX|66|TX| Margins Examined: Distal OBX|67|TX| OBX|68|TX|LYMPH NODES, REGIONAL OBX|69|TX| No lymph nodes present OBX|70|TX| OBX|71|TX|TREATMENT EFFECT OBX|72|TX| Extensive residual cancer with no evident OBX|73|TX| tumour regression (poor or no response, OBX|74|TX| score 3) OBX|75|TX| OBX|76|TX|PATHOLOGIC STAGE OBX|77|TX| ypT4 pNX OBX|78|TX| OBX|79|TX|ANCILLARY STUDIES OBX|80|TX| Best Tumour Block(s): test OBX|81|TX| OBX|82|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|83|TX|---------- End of Synoptic Report ---------- OBX|84|TX|-------- Breast Invasive Carcinoma, 3 -------- OBX|85|TX| OBX|86|TX|SPECIMEN COMMENT OBX|87|TX| Pertains To: testing v.7.0.0.27 OBX|88|TX| OBX|89|TX|SPECIMEN OBX|90|TX| Skin, Nipple, and Breast; Total mastectomy; OBX|91|TX| Left OBX|92|TX| OBX|93|TX|TUMOUR OBX|94|TX| Invasive Carcinoma: Present OBX|95|TX| Histologic Type: Invasive carcinoma of no special type OBX|96|TX| (ductal, not otherwise specified) OBX|97|TX| Histologic Grade (Nottingham OBX|98|TX| Histologic Score) OBX|99|TX| Glandular (Acinar) / Tubular OBX|100|TX| Differentiation: Score 3 OBX|101|TX| Nuclear Pleomorphism: Score 3 OBX|102|TX| Mitotic Rate: Score 2 OBX|103|TX| Overall Nottingham Score: Grade 3 OBX|104|TX| Tumour Size: 3 Millimeters (mm) OBX|105|TX| Tumour Focality: Single focus of invasive carcinoma OBX|106|TX| Lymphovascular Invasion: Present OBX|107|TX| Skin Invasion: Skin is uninvolved OBX|108|TX| Skin Satellite Foci: Satellite foci not identified OBX|109|TX| Nipple DCIS: DCIS does not involve the nipple epidermis OBX|110|TX| In Situ Component: Not identified OBX|111|TX| OBX|112|TX|MARGINS OBX|113|TX| Invasive Carcinoma Margins: Negative for invasive carcinoma OBX|114|TX| Distance from Closest Margin: Greater than: 4 Millimeters (mm) OBX|115|TX| Closest Margin: Medial OBX|116|TX| DCIS Margins: No DCIS present in specimen OBX|117|TX| OBX|118|TX|LYMPH NODES, REGIONAL OBX|119|TX| No lymph nodes present OBX|120|TX| OBX|121|TX|TREATMENT EFFECT OBX|122|TX| Treatment information not provided OBX|123|TX| OBX|124|TX|PATHOLOGIC STAGE OBX|125|TX| pT1a pNX OBX|126|TX| OBX|127|TX|ANCILLARY STUDIES OBX|128|TX| Best Tumour Block(s): test OBX|129|TX| Block Tested: test OBX|130|TX| Results OBX|131|TX| ER: Negative (Intensity: Negative, 0%), Allred OBX|132|TX| Score: 0/8 OBX|133|TX| Controls OBX|134|TX| ER Internal Positive Control: Present OBX|135|TX| OBX|136|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|137|TX|---------- End of Synoptic Report ---------- OBX|138|TX|-------- Breast Invasive Carcinoma, 4 -------- OBX|139|TX| OBX|140|TX|SPECIMEN COMMENT OBX|141|TX| Pertains To: testing v.7.0.0.28 OBX|142|TX| OBX|143|TX|SPECIMEN OBX|144|TX| Breast; Total mastectomy; Left OBX|145|TX| OBX|146|TX|TUMOUR OBX|147|TX| Invasive Carcinoma: Present OBX|148|TX| Histologic Type: Invasive carcinoma with lobular features OBX|149|TX| Histologic Grade (Nottingham OBX|150|TX| Histologic Score) OBX|151|TX| Glandular (Acinar) / Tubular OBX|152|TX| Differentiation: Score 2 OBX|153|TX| Nuclear Pleomorphism: Score 2 OBX|154|TX| Mitotic Rate: Score 3 OBX|155|TX| Overall Nottingham Score: Grade 2 OBX|156|TX| Tumour Size: Microinvasion only (<= 1 mm) OBX|157|TX| Tumour Focality: Single focus of invasive carcinoma OBX|158|TX| Lymphovascular Invasion: Present OBX|159|TX| In Situ Component: Not identified OBX|160|TX| OBX|161|TX|MARGINS OBX|162|TX| Invasive Carcinoma Margins: Cannot be assessed OBX|163|TX| DCIS Margins: No DCIS present in specimen OBX|164|TX| OBX|165|TX|LYMPH NODES, REGIONAL OBX|166|TX| No lymph nodes present OBX|167|TX| OBX|168|TX|TREATMENT EFFECT OBX|169|TX| Presurgical therapy OBX|170|TX| In the Breast: No residual invasive carcinoma is present in OBX|171|TX| the breast after presurgical therapy OBX|172|TX| OBX|173|TX|PATHOLOGIC STAGE OBX|174|TX| pT1mi pNX OBX|175|TX| OBX|176|TX|ANCILLARY STUDIES OBX|177|TX| Best Tumour Block(s): test OBX|178|TX| Biomarker Testing/Results: Not performed: test OBX|179|TX| OBX|180|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|181|TX|---------- End of Synoptic Report ---------- OBX|182|TX|-------- Breast DCIS, 5 -------- OBX|183|TX| OBX|184|TX|SPECIMEN COMMENT OBX|185|TX| Pertains To: testing v.7.0.0.13 OBX|186|TX| OBX|187|TX|SPECIMEN OBX|188|TX| Procedure: Excision (less than total mastectomy) OBX|189|TX| Specimen Laterality: Right OBX|190|TX| OBX|191|TX|TUMOUR OBX|192|TX| Estimated Size (extent) of DCIS: test OBX|193|TX| Histologic Type: Ductal carcinoma in situ OBX|194|TX| Nuclear Grade: Grade I (low) OBX|195|TX| Necrosis: Present, focal (small foci or single cell OBX|196|TX| necrosis) OBX|197|TX| OBX|198|TX|MARGINS OBX|199|TX| Cannot be assessed - test OBX|200|TX| OBX|201|TX|LYMPH NODES, REGIONAL OBX|202|TX| No lymph nodes present OBX|203|TX| OBX|204|TX|PATHOLOGIC STAGE OBX|205|TX| pTis (DCIS) pN0 OBX|206|TX| OBX|207|TX|ANCILLARY STUDIES OBX|208|TX| Best Tumour Block(s): testing OBX|209|TX| Biomarker Testing/Results: Submitted, see separate report: test OBX|210|TX| OBX|211|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|212|TX|---------- End of Synoptic Report ---------- OBX|213|TX|-------- Endometrium - Hysterectomy, 6 -------- OBX|214|TX| OBX|215|TX|SPECIMEN COMMENT OBX|216|TX| Pertains To: testing v.7.0.0.14 OBX|217|TX| OBX|218|TX|SPECIMEN OBX|219|TX| Procedure: Radical hysterectomy OBX|220|TX| OBX|221|TX|TUMOUR OBX|222|TX| Histologic Type: Endometrioid carcinoma, NOS OBX|223|TX| Histologic Grade: FIGO grade 2 OBX|224|TX| Tumour Size: 3 Centimeters (cm) OBX|225|TX| Myometrial Invasion: Not identified OBX|226|TX| Cervical Stromal Invasion: Present OBX|227|TX| Other Tissue Involvement / Organ OBX|228|TX| Involvement: Left ovary OBX|229|TX| Lymph Vascular Invasion: Focal (2 or fewer) OBX|230|TX| OBX|231|TX|MARGINS OBX|232|TX| Parametrial / Paracervical Margin: Positive for carcinoma OBX|233|TX| OBX|234|TX|LYMPH NODES, REGIONAL OBX|235|TX| No lymph nodes present OBX|236|TX| OBX|237|TX|PATHOLOGIC STAGE OBX|238|TX| pT3a pNX pM1 OBX|239|TX| pM Site(s): Lung OBX|240|TX| OBX|241|TX|ANCILLARY STUDIES OBX|242|TX| Best Tumour Block(s): testing OBX|243|TX| Biomarker Testing: Performed previously: test OBX|244|TX| OBX|245|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|246|TX|---------- End of Synoptic Report ---------- OBX|247|TX|-------- GIST - Biopsy, 7 -------- OBX|248|TX| OBX|249|TX|SPECIMEN COMMENT OBX|250|TX| Pertains To: testing v.7.0.0.7 OBX|251|TX| OBX|252|TX|SPECIMEN OBX|253|TX| Procedure: Endoscopic biopsy OBX|254|TX| OBX|255|TX|TUMOUR OBX|256|TX| Tumour Site: Small Intestine OBX|257|TX| Histologic Type: GIST, epithelioid type OBX|258|TX| Histologic Grade: G2: High grade; mitotic rate > 5 / 5 mm2 OBX|259|TX| Risk Assessment: High risk OBX|260|TX| OBX|261|TX|TREATMENT EFFECT OBX|262|TX| Present OBX|263|TX| OBX|264|TX|ANCILLARY STUDIES OBX|265|TX| Best Tumour Block(s): test OBX|266|TX| Biomarker Testing / Results: Performed, addendum to follow: test OBX|267|TX| OBX|268|TX| OBX|269|TX| OBX|270|TX| Risk Assessment reference: 1 Miettinen M, OBX|271|TX| Lasota J. Gastrointestinal stromal tumors: OBX|272|TX| pathology and prognosis at different sites. OBX|273|TX| Semin Diagn Pathol. 2006;23(2):70-83. OBX|274|TX| OBX|275|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|276|TX|---------- End of Synoptic Report ---------- OBX|277|TX|-------- Lung - Resection, 8 -------- OBX|278|TX| OBX|279|TX|SPECIMEN COMMENT OBX|280|TX| Pertains To: testing v.7.0.0.13 OBX|281|TX| OBX|282|TX|SPECIMEN OBX|283|TX| Procedure: Wedge resection OBX|284|TX| Specimen Laterality: Left OBX|285|TX| OBX|286|TX|TUMOUR OBX|287|TX| Tumour Site: Lower lobe OBX|288|TX| Tumour Focality: Separate tumour nodules of same OBX|289|TX| histopathologic type (intrapulmonary OBX|290|TX| metastases) in same lobe OBX|291|TX| Tumour Size: 4 Centimeters (cm) OBX|292|TX| Histologic Type: Minimally invasive adenocarcinoma, OBX|293|TX| nonmucinous OBX|294|TX| Visceral Pleura Invasion: Present OBX|295|TX| Direct Invasion of Adjacent OBX|296|TX| Structures: Adjacent structures present but not involved OBX|297|TX| Lymphovascular Invasion: Present OBX|298|TX| OBX|299|TX|MARGINS OBX|300|TX| All margins are negative for carcinoma OBX|301|TX| Margins Examined: Bronchial, Vascular, Parenchymal OBX|302|TX| OBX|303|TX|LYMPH NODES, REGIONAL OBX|304|TX| No lymph nodes present OBX|305|TX| OBX|306|TX|TREATMENT EFFECT OBX|307|TX| No known presurgical therapy OBX|308|TX| OBX|309|TX|PATHOLOGIC STAGE OBX|310|TX| pT3 pNX OBX|311|TX| OBX|312|TX|ANCILLARY STUDIES OBX|313|TX| Best Tumour Block(s): test OBX|314|TX| Biomarker Testing/Results: Performed, see separate report: test OBX|315|TX| OBX|316|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|317|TX|---------- End of Synoptic Report ---------- OBX|318|TX|-------- Stomach, 9 -------- OBX|319|TX| OBX|320|TX|SPECIMEN COMMENT OBX|321|TX| Pertains To: testing v.7.0.0.5 OBX|322|TX| OBX|323|TX|SPECIMEN OBX|324|TX| Procedure: Total gastrectomy OBX|325|TX| OBX|326|TX|TUMOUR OBX|327|TX| Tumour Site: Fundus OBX|328|TX| Tumour Size: 4 Centimeters (cm) OBX|329|TX| Histologic Type: Large cell neuroendocrine carcinoma OBX|330|TX| Histologic Grade: G3: Poorly differentiated, undifferentiated OBX|331|TX| Tumour Extension: Tumour invades the submucosa OBX|332|TX| Lymphovascular Invasion: Present OBX|333|TX| OBX|334|TX|TREATMENT EFFECT OBX|335|TX| Residual cancer with evident tumour OBX|336|TX| regression, but more than single cells or OBX|337|TX| rare small groups of cancer cells (partial OBX|338|TX| response, score 2) OBX|339|TX| OBX|340|TX|MARGINS OBX|341|TX| Proximal Margin: Negative for invasive carcinoma OBX|342|TX| Status of Dysplasia at Proximal Positive for carcinoma in situ (high-grade OBX|343|TX| Margin: dysplasia) OBX|344|TX| Distal Margin: Negative for invasive carcinoma OBX|345|TX| Status of Dysplasia at Distal Positive for carcinoma in situ (high-grade OBX|346|TX| Margin: dysplasia) OBX|347|TX| Omental (Radial) Margins: Negative for invasive carcinoma OBX|348|TX| OBX|349|TX|LYMPH NODES, REGIONAL OBX|350|TX| No lymph nodes present OBX|351|TX| OBX|352|TX|PATHOLOGIC STAGE OBX|353|TX| pT1b pNX OBX|354|TX| OBX|355|TX|ANCILLARY STUDIES OBX|356|TX| Best Tumour Block(s): test OBX|357|TX| Biomarker Testing/Results: Not performed: test OBX|358|TX| OBX|359|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|360|TX|---------- End of Synoptic Report ---------- OBX|361|TX|-------- Ureter Renal Pelvis - Biopsy, 10 -------- OBX|362|TX| OBX|363|TX|SPECIMEN OBX|364|TX| Specimen: Renal pelvis OBX|365|TX| Specimen Laterality: Right OBX|366|TX| OBX|367|TX|TUMOUR OBX|368|TX| Tumour Configuration: Flat OBX|369|TX| Histologic Type: Urothelial carcinoma, invasive OBX|370|TX| Histologic Grade: High-grade OBX|371|TX| Tumour Extension: Tumour invades the muscularis OBX|372|TX| OBX|373|TX|ANCILLARY STUDIES OBX|374|TX| Best Tumour Block(s): test OBX|375|TX| Biomarker Testing/Results: Performed previously: test OBX|376|TX| OBX|377|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|378|TX|---------- End of Synoptic Report ---------- OBX|379|TX|-------- Colon and Rectum - Resection, 11 -------- OBX|380|TX| OBX|381|TX|SPECIMEN COMMENT OBX|382|TX| Pertains To: testing v.7.0.0.20 OBX|383|TX| OBX|384|TX|SPECIMEN OBX|385|TX| Procedure: Right hemicolectomy OBX|386|TX| Macroscopic Tumour Perforation: Present OBX|387|TX| OBX|388|TX|TUMOUR OBX|389|TX| Tumour Site: Cecum OBX|390|TX| Histologic Type: Adenocarcinoma OBX|391|TX| Histologic Grade: G1: Well differentiated (Low grade) OBX|392|TX| Tumour Size: 4 Centimeters (cm) OBX|393|TX| Tumour Extension: Tumour invades through the muscularis OBX|394|TX| propria into pericolorectal tissue OBX|395|TX| Lymphovascular Invasion: Present OBX|396|TX| Perineural Invasion: Present OBX|397|TX| OBX|398|TX|MARGINS OBX|399|TX| Proximal Margin: Cannot be assessed OBX|400|TX| Distal Margin: Cannot be assessed OBX|401|TX| Radial or Mesenteric Margin: Not applicable OBX|402|TX| OBX|403|TX|LYMPH NODES, REGIONAL OBX|404|TX| No lymph nodes present OBX|405|TX| OBX|406|TX|TREATMENT EFFECT OBX|407|TX| Single cells or rare small groups of cancer OBX|408|TX| cells (near complete response, score 1) OBX|409|TX| OBX|410|TX|PATHOLOGIC STAGE OBX|411|TX| pT3 pNX OBX|412|TX| OBX|413|TX|ANCILLARY STUDIES OBX|414|TX| Best Tumour Block(s): test OBX|415|TX| Biomarker Testing: Not performed: test OBX|416|TX| OBX|417|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|418|TX|---------- End of Synoptic Report ---------- OBX|419|TX|-------- GIST - Resection, 12 -------- OBX|420|TX| OBX|421|TX|SPECIMEN COMMENT OBX|422|TX| Pertains To: Testing v.7.0.0.5 OBX|423|TX| OBX|424|TX|SPECIMEN OBX|425|TX| Procedure: Resection OBX|426|TX| Type: test OBX|427|TX| OBX|428|TX|TUMOUR OBX|429|TX| Tumour Site: Colon OBX|430|TX| Tumour Size: 4 Centimeters (cm) OBX|431|TX| Tumour Focality: Unifocal OBX|432|TX| Histologic Type: GIST, spindle cell type OBX|433|TX| Histologic Grade: G2: High grade; mitotic rate > 5 / 5 mm2 OBX|434|TX| Mitotic Rate: 4 mitoses per 5 mm2 OBX|435|TX| Risk Assessment: Low risk OBX|436|TX| OBX|437|TX|MARGINS OBX|438|TX| Negative for GIST OBX|439|TX| Distance of Tumour from Closest OBX|440|TX| Margin: 3 Millimeters (mm) OBX|441|TX| OBX|442|TX|LYMPH NODES, REGIONAL OBX|443|TX| No lymph nodes present OBX|444|TX| OBX|445|TX|TREATMENT EFFECT OBX|446|TX| Preresection Treatment: Systemic therapy performed - test OBX|447|TX| Treatment Effect: Present OBX|448|TX| OBX|449|TX|PATHOLOGIC STAGE OBX|450|TX| pT2 pN0 OBX|451|TX| OBX|452|TX|ANCILLARY STUDIES OBX|453|TX| Best Tumour Block(s): test OBX|454|TX| Biomarker Testing / Results: Performed, see separate report: test OBX|455|TX| OBX|456|TX| OBX|457|TX| OBX|458|TX| Risk Assessment reference: 1 Miettinen M, OBX|459|TX| Lasota J. Gastrointestinal stromal tumors: OBX|460|TX| pathology and prognosis at different sites. OBX|461|TX| Semin Diagn Pathol. 2006;23(2):70-83. OBX|462|TX| OBX|463|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|464|TX|---------- End of Synoptic Report ---------- OBX|465|TX|-------- Ureter Renal Pelvis - Biopsy, 13 -------- OBX|466|TX| OBX|467|TX|SPECIMEN COMMENT OBX|468|TX| Pertains To: testing v.7.0.0.4 OBX|469|TX| OBX|470|TX|SPECIMEN OBX|471|TX| Specimen: Ureter OBX|472|TX| OBX|473|TX|TUMOUR OBX|474|TX| Tumour Configuration: Papillary OBX|475|TX| Histologic Type: Urothelial carcinoma, invasive OBX|476|TX| Histologic Grade: High-grade OBX|477|TX| Tumour Extension: Tumour invades subepithelial connective OBX|478|TX| tissue OBX|479|TX| OBX|480|TX|ANCILLARY STUDIES OBX|481|TX| Best Tumour Block(s): test OBX|482|TX| Biomarker Testing/Results: Performed, see separate report: test OBX|483|TX| OBX|484|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|485|TX|---------- End of Synoptic Report ---------- OBX|486|TX|-------- Colon and Rectum Excisional Biopsy (Polypectomy), 14 -------- OBX|487|TX| OBX|488|TX|SPECIMEN COMMENT OBX|489|TX| Pertains To: testing OBX|490|TX| OBX|491|TX|TUMOUR OBX|492|TX| Tumour Site: Cecum OBX|493|TX| Histologic Type: Adenocarcinoma OBX|494|TX| Histologic Grade: G1: Well differentiated (Low grade) OBX|495|TX| Tumour Extension: Tumour invades submucosa OBX|496|TX| Lymphovascular Invasion: Present OBX|497|TX| OBX|498|TX|MARGINS OBX|499|TX| Deep Margin: Negative for invasive carcinoma OBX|500|TX| Distance of Invasive Carcinoma OBX|501|TX| from Margin: 4 Millimeters (mm) OBX|502|TX| Mucosal Margin: Negative for invasive carcinoma OBX|503|TX| OBX|504|TX|PATHOLOGIC STAGE OBX|505|TX| pT1 OBX|506|TX| OBX|507|TX|ANCILLARY STUDIES OBX|508|TX| Best Tumour Block(s): test OBX|509|TX| Biomarker Testing: Not performed: test OBX|510|TX| OBX|511|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|512|TX|---------- End of Synoptic Report ---------- OBX|513|TX|-------- Adrenal - Biopsy; Resection, 15 -------- OBX|514|TX| OBX|515|TX|SPECIMEN COMMENT OBX|516|TX| Pertains To: testing v.7.0.0.6 OBX|517|TX| OBX|518|TX|SPECIMEN OBX|519|TX| Procedure: Adrenalectomy, total OBX|520|TX| Specimen Laterality: Bilateral OBX|521|TX| OBX|522|TX|TUMOUR OBX|523|TX| Tumour Size: 4 Centimeters (cm) OBX|524|TX| Weight: 3 g OBX|525|TX| Histologic Type: Adrenal cortical carcinoma, oncocytic type OBX|526|TX| Histologic Grade: High grade OBX|527|TX| Tumour Extension: Tumour invades into or through the adrenal OBX|528|TX| capsule OBX|529|TX| Lymphovascular Invasion: Large vessel invasion, not otherwise OBX|530|TX| specified; Microscopic angioinvasion OBX|531|TX| Tumour Description: Necrotic OBX|532|TX| OBX|533|TX|MARGINS OBX|534|TX| Negative for tumour OBX|535|TX| Margin: test OBX|536|TX| OBX|537|TX|LYMPH NODES, REGIONAL OBX|538|TX| No lymph nodes present OBX|539|TX| OBX|540|TX|PATHOLOGIC STAGE OBX|541|TX| mpT1 pNX OBX|542|TX| OBX|543|TX|ANCILLARY STUDIES OBX|544|TX| Best Tumour Block(s): test OBX|545|TX| Ancillary Studies: Ki-67 labeling index - 4%, Reticulin stain - OBX|546|TX| test, test OBX|547|TX| OBX|548|TX|COMMENTS OBX|549|TX| test OBX|550|TX| OBX|551|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|552|TX|---------- End of Synoptic Report ---------- OBX|553|TX|-------- Prostate - Needle Biopsy Summary, 16 -------- OBX|554|TX| OBX|555|TX|SPECIMEN COMMENT OBX|556|TX| Pertains To: testing v.2.0.0.27 OBX|557|TX| OBX|558|TX|TUMOUR OBX|559|TX| Histologic Type: Adenocarcinoma (acinar) OBX|560|TX| Histologic Grade OBX|561|TX| Grade Group and Gleason Score: Grade group 3 (Gleason Score 4 + 3 = 7) OBX|562|TX| Percentage of Pattern 4: 60% OBX|563|TX| Lymph-Vascular Invasion: Present OBX|564|TX| Total Number of Cores: 6 OBX|565|TX| Number of Positive Cores: 1 OBX|566|TX| Number of Cores Positive on Left OBX|567|TX| Side: 1 OBX|568|TX| Number of Cores Positive on Right OBX|569|TX| Side: 0 OBX|570|TX| Total Linear Span of Carcinoma in OBX|571|TX| Cores: 5 mm OBX|572|TX| Total Length of Positive Needle OBX|573|TX| Cores: 10 mm OBX|574|TX| Proportion of Positive Cores OBX|575|TX| Involved by Tumour: 50 % OBX|576|TX| Periprostatic Fat Invasion: Present OBX|577|TX| Seminal Vesicle Invasion: Present OBX|578|TX| OBX|579|TX|Based on AJCC/UICC TNM, 7th edition OBX|580|TX|---------- End of Synoptic Report ---------- OBX|581|TX|-------- Prostate - Radical Prostatectomy, 17 -------- OBX|582|TX| OBX|583|TX|SPECIMEN COMMENT OBX|584|TX| Pertains To: testing v.7.0.0.16 OBX|585|TX| OBX|586|TX|SPECIMEN OBX|587|TX| Procedure: Radical prostatectomy OBX|588|TX| OBX|589|TX|TUMOUR OBX|590|TX| Histologic Type: Acinar adenocarcinoma OBX|591|TX| Histologic Grade OBX|592|TX| Grade Group and Gleason Score: Grade group 5 (Gleason Score 5 + 4 = 9) OBX|593|TX| Tertiary Gleason Pattern: Grade 3 OBX|594|TX| Percentage of Pattern 4: 25 % OBX|595|TX| Percentage of Pattern 5: 50 % OBX|596|TX| Extraprostatic Extension (EPE): Not identified OBX|597|TX| Urinary Bladder Neck Invasion: Not identified OBX|598|TX| Seminal Vesicle Invasion: Present OBX|599|TX| Treatment Effect: No known presurgical therapy OBX|600|TX| OBX|601|TX|MARGINS OBX|602|TX| Negative for invasive carcinoma OBX|603|TX| OBX|604|TX|LYMPH NODES, REGIONAL OBX|605|TX| No lymph nodes present OBX|606|TX| OBX|607|TX|PATHOLOGIC STAGE OBX|608|TX| pT3b pNX OBX|609|TX| OBX|610|TX|ANCILLARY STUDIES OBX|611|TX| Best Tumour Block(s): test OBX|612|TX| OBX|613|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|614|TX|---------- End of Synoptic Report ---------- OBX|615|TX|-------- Prostate - Radical Prostatectomy, 18 -------- OBX|616|TX| OBX|617|TX|SPECIMEN COMMENT OBX|618|TX| Pertains To: testing v.7.0.0.17 OBX|619|TX| OBX|620|TX|SPECIMEN OBX|621|TX| Procedure: Radical prostatectomy OBX|622|TX| OBX|623|TX|TUMOUR OBX|624|TX| Histologic Type: Acinar adenocarcinoma OBX|625|TX| Histologic Grade OBX|626|TX| Grade Group and Gleason Score: Grade group 4 (Gleason Score 5 + 3 = 8) OBX|627|TX| Tertiary Gleason Pattern: Grade 4 OBX|628|TX| Percentage of Pattern 4: 25 % OBX|629|TX| Percentage of Pattern 5: 50 % OBX|630|TX| Extraprostatic Extension (EPE): Present, focal OBX|631|TX| Urinary Bladder Neck Invasion: Not identified OBX|632|TX| Seminal Vesicle Invasion: Not identified OBX|633|TX| Treatment Effect: Not identified OBX|634|TX| OBX|635|TX|MARGINS OBX|636|TX| Negative for invasive carcinoma OBX|637|TX| OBX|638|TX|LYMPH NODES, REGIONAL OBX|639|TX| No lymph nodes present OBX|640|TX| OBX|641|TX|PATHOLOGIC STAGE OBX|642|TX| pT3a pNX OBX|643|TX| OBX|644|TX|ANCILLARY STUDIES OBX|645|TX| Best Tumour Block(s): test OBX|646|TX| OBX|647|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|648|TX|---------- End of Synoptic Report ---------- OBX|649|TX|-------- Prostate - TUR; Enucleation Specimen, 19 -------- OBX|650|TX| OBX|651|TX|SPECIMEN COMMENT OBX|652|TX| Pertains To: testing v.7.0.0.6 OBX|653|TX| OBX|654|TX|SPECIMEN OBX|655|TX| Procedure: Enucleation OBX|656|TX| OBX|657|TX|TUMOUR OBX|658|TX| Histologic Type: Ductal adenocarcinoma OBX|659|TX| Histologic Grade OBX|660|TX| Grade Group and Gleason Score: Grade group 5 (Gleason Score 5 + 5 = 10) OBX|661|TX| Percentage of Pattern 5: 100% OBX|662|TX| Estimated Percentage of Prostatic OBX|663|TX| Tissue Involved by Tumour: 25% OBX|664|TX| Periprostatic Fat Invasion: Present OBX|665|TX| OBX|666|TX|ANCILLARY STUDIES OBX|667|TX| Best Tumour Block(s): test OBX|668|TX| OBX|669|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|670|TX|---------- End of Synoptic Report ---------- OBX|671|TX|-------- Testis - Orchiectomy, 20 -------- OBX|672|TX| OBX|673|TX|SPECIMEN COMMENT OBX|674|TX| Pertains To: testing v.7.0.0.8 OBX|675|TX| OBX|676|TX|SPECIMEN OBX|677|TX| Specimen Laterality: Not specified OBX|678|TX| OBX|679|TX|TUMOUR OBX|680|TX| Histologic Type: Sex cord-stromal tumour type, unclassified; OBX|681|TX| Mixed germ cell-sex cord stromal tumour, OBX|682|TX| gonadoblastoma OBX|683|TX| Histologic Type Comments: test OBX|684|TX| Tumour Focality: Unifocal OBX|685|TX| Tumour Size: 4 Centimeters (cm) OBX|686|TX| Tumour Extension: Tumour invades hilar soft tissue OBX|687|TX| Lymphovascular Invasion: Present OBX|688|TX| OBX|689|TX|MARGINS OBX|690|TX| Spermatic Cord Margin: Negative for tumour OBX|691|TX| Other Margin(s): Negative for tumour OBX|692|TX| Margin(s): test OBX|693|TX| OBX|694|TX|LYMPH NODES, REGIONAL OBX|695|TX| No lymph nodes present OBX|696|TX| OBX|697|TX|PATHOLOGIC STAGE OBX|698|TX| pT2 pNX OBX|699|TX| OBX|700|TX|ANCILLARY STUDIES OBX|701|TX| Best Tumour Block(s): test OBX|702|TX| OBX|703|TX|ADDITIONAL FINDINGS OBX|704|TX| Microlith OBX|705|TX| OBX|706|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|707|TX|---------- End of Synoptic Report ---------- OBX|708|TX|-------- Urinary Bladder - Biopsy; TURBT, 21 -------- OBX|709|TX| OBX|710|TX|SPECIMEN COMMENT OBX|711|TX| Pertains To: testing v.7.0.0.4 OBX|712|TX| OBX|713|TX|SPECIMEN OBX|714|TX| Procedure: Transurethral resection of bladder (TURBT) OBX|715|TX| OBX|716|TX|TUMOUR OBX|717|TX| Tumour Site: Dome OBX|718|TX| Histologic Type: Urothelial carcinoma, invasive OBX|719|TX| Histologic Grade: G1: Well differentiated OBX|720|TX| Muscularis Propria Presence: Muscularis propria (detrusor muscle) present OBX|721|TX| Tumour Extension: Urothelial carcinoma involving prostatic OBX|722|TX| urethra in prostatic chips sampled by TURBT OBX|723|TX| Lymphovascular Invasion: Present OBX|724|TX| OBX|725|TX|ANCILLARY STUDIES OBX|726|TX| Best Tumour Block(s): test OBX|727|TX| OBX|728|TX|ADDITIONAL PATHOLOGIC FINDINGS OBX|729|TX| Urothelial dysplasia OBX|730|TX| OBX|731|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|732|TX|---------- End of Synoptic Report ---------- OBX|733|TX|-------- Urinary Bladder - Cystectomy, 22 -------- OBX|734|TX| OBX|735|TX|SPECIMEN COMMENT OBX|736|TX| Pertains To: testing v.7.0.0.7 OBX|737|TX| OBX|738|TX|SPECIMEN OBX|739|TX| Procedure: Radical cystectomy (total cystectomy) OBX|740|TX| OBX|741|TX|TUMOUR OBX|742|TX| Tumour Site: Dome OBX|743|TX| Histologic Type: Urothelial carcinoma invasive OBX|744|TX| Histologic Grade: G2: Moderately differentiated OBX|745|TX| Tumour Size: 4 Centimeters (cm) OBX|746|TX| Tumour Extension: Tumour invades perivesical tissue OBX|747|TX| Extent of Perivesical Invasion: Microscopically OBX|748|TX| Tumour Configuration: Ulcerated OBX|749|TX| Lymphovascular Invasion: Present OBX|750|TX| OBX|751|TX|MARGINS OBX|752|TX| Negative for invasive carcinoma and OBX|753|TX| carcinoma in situ / noninvasive urothelial OBX|754|TX| carcinoma OBX|755|TX| OBX|756|TX|LYMPH NODES, REGIONAL OBX|757|TX| No lymph nodes present OBX|758|TX| OBX|759|TX|PATHOLOGIC STAGE OBX|760|TX| pT3a pNX OBX|761|TX| OBX|762|TX|ANCILLARY TESTING OBX|763|TX| Best Tumour Block(s): test OBX|764|TX| OBX|765|TX|ADDITIONAL PATHOLOGIC FINDINGS OBX|766|TX| Urothelial dysplasia OBX|767|TX| OBX|768|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|769|TX|---------- End of Synoptic Report ---------- OBX|770|TX|-------- Breast Biomarkers, 23 -------- OBX|771|TX| OBX|772|TX|SPECIMEN OBX|773|TX| Submitting Hospital Case Number: ; Block OBX|774|TX| Tested: test OBX|775|TX| OBX|776|TX|BREAST BIOMARKER TESTS OBX|777|TX| Ki-67: Low (Less than 10%) OBX|778|TX| OBX|779|TX|---------- End of Synoptic Report ---------- OBX|780|TX| OBX|781|TX|SPECIMEN SUBMITTED OBX|782|TX|TURB OBX|783|TX| ____________________________________ OBX|784|TX| Brigette Rabel OBX|785|TX| Electronically signed: 28/Nov/2019 OBX|786|TX| OBX|787|TX|-------------------------------------------------------------------------------------------- OBX|788|TX| OBX|789|TX| OBX|790|TX| OBX|791|TX| OBX|792|TX| OBX|793|TX| OBX|794|TX| OBX|795|TX| OBX|796|TX| OBX|797|TX| OBX|798|TX| OBX|799|TX| OBX|800|TX| OBX|801|TX| OBX|802|TX| OBX|803|TX| OBX|804|TX| OBX|805|TX| OBX|806|TX| OBX|807|TX| OBX|808|TX| OBX|809|TX|